Intraocular inflammation following intravitreal injection of bevacizumab
The DOI matches its Crossref record; 11 of the 11 references it cites were found in a registry or an index.
Abstract
Background Injection of drugs into the vitreous can lead to intraocular inflammation through infectious and non-infectious processes. Failure to recognize an eye with anterior chamber and vitreous cell as sterile inflammation can lead to unnecessary treatment for endophthalmitis.Methods Four cases of uveitis following intravitreal bevacizumab (Avastin) for exudative age-related macular degeneration are described followed by review of the literature.Results Four patients presented with uveitis. Two patients presented with pain and red eye associated with iritis and two patients with vitritis, several days following intravitreal injection of bevacizumab. No paracentesis was performed and no corneal epithelial defect was created. Both patients with iritis were presumed to have sterile intraocular inflammation since the anterior chamber cell was much greater than the vitreous cell and resolved with cycloplegic and topical corticosteroid therapy. The third patient presented only with vitreous cell which resolved without therapy. The fourth patient had anterior chamber cell and vitreous cell with clumps, which resolved with topical prednisolone acetate. The inflammation resolved in all cases within 1 to 2 weeks.Conclusion There are few published cases of uveitis following bevacizumab. With its rising use, it is important to be aware of its potential to be associated with intraocular inflammation.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Inflammatory reactions have also been reported after intravitreal injection of ranibizumab, however the reported rates of inflammation have typically been lower [29].”
From Mechanisms of sterile inflammation after intravitreal injection of antiangiogenic drugs: a narrative review (2021) · cites this paper as [29]
Citations
Cites
Ranibizumab for Neovascular Age-Related Macular Degeneration
Rosenfeld, P. J., Brown, D. M., Heier, J. S., Boyer, D. S., Kaiser, P. K., Chung, C. Y., & Kim, R. Y. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa054481 · Cited by 5,886
SPAIDE, R. F., LAUD, K., FINE, H. F., KLANCNIK, J. M., MEYERLE, C. B., YANNUZZI, L. A., SORENSON, J., SLAKTER, J., FISHER, Y. L., & COONEY, M. J. (2006) · Retina · doi:10.1097/00006982-200604000-00001 · Cited by 630 · cited 2×
“Both cases resolved without treatment [1].”
BackgroundAcute endophthalmitis following intravitreal triamcinolone acetonide injection
Moshfeghi, D. M., Kaiser, P. K., Scott, I. U., Sears, J. E., Benz, M., Sinesterra, J. P., Kaiser, R. S., Bakri, S. J., Maturi, R. K., Belmont, J., et al. (2003) · American Journal of Ophthalmology · doi:10.1016/s0002-9394(03)00483-5 · Cited by 397
Self-citationNoninfectious Endophthalmitis Associated With Intravitreal Triamcinolone Injection
Roth, D. B. (2003) · Archives of Ophthalmology · doi:10.1001/archopht.121.9.1279 · Cited by 285 · cited 1×
“Other factors that may be associated with a noninfectious inflammatory reaction with intravitreal injections include a prior history of uveitis, pseudophakia, and past history of vitrectomy [6, 9 ]. Taban et al. reported that four of six cases of sterile endophthalmitis occurring after IVTA were in patients with a pri…”
BackgroundROSENFELD, P., SCHWARTZ, S., BLUMENKRANZ, M., MILLER, J., HALLER, J., REIMANN, J., GREENE, W., & SHAMS, N. (2005) · Ophthalmology · doi:10.1016/j.ophtha.2005.01.043 · Cited by 223 · cited 1×
“For example, in pre-clinical trials of ranibizumab, also an antibody to VEGF-A, the dose limiting factor was intraocular inflammation thought secondary to the lyophilized formulation [ 8 ].”
BackgroundInfectious and Noninfectious Endophthalmitis After Intravitreal Bevacizumab
Jonas, J. B., Spandau, U. H., Rensch, F., von Baltz, S., & Schlichtenbrede, F. C. (2007) · Journal of Ocular Pharmacology and Therapeutics · doi:10.1089/jop.2006.0146 · Cited by 75 · cited 1×
“1% per injection [2] similar to other anti-VEGF agents such as intravitreal ranibzumab or pegaptanib (up to 0.”
BackgroundACUTE ENDOPHTHALMITIS FOLLOWING INTRAVITREAL TRIAMCINOLONE ACETONIDE INJECTION
Regillo, C. (2004) · Evidence-Based Eye Care · doi:10.1097/00132578-200404000-00006 · Cited by 63 · cited 1×
“The rates of sterile endophthalmitis with bevacizumab have yet to be determined, however, with intravitreal ranibizumab are up to 1.3% of patients [4] and with intravitreal triamcinolone are up to 1.9% [ 5 , 6]. Here we report four cases of presumed noninfectious uveitis following intravitreal bevacizumab (IVB).”
BackgroundInfluentialEVALUATION OF ANTERIOR CHAMBER INFLAMMATORY ACTIVITY IN EYES TREATED WITH INTRAVITREAL BEVACIZUMAB
Kiss, C., Michels, S., Prager, F., Weigert, G., Geitzenauer, W., & Schmidt-Erfurth, U. M. (2006) · Retina · doi:10.1097/01.iae.0000237080.10627.b7 · Cited by 60
CASE OF ANTERIOR UVEITIS AFTER INTRAVITREAL INJECTION OF BEVACIZUMAB
Pieramici, D. J., Avery, R. L., CASTELLARIN, A. A., Nasir, M. A., & Rabena, M. (2006) · Retina · doi:10.1097/01.iae.0000234629.22614.cd · Cited by 54 · cited 1×
“reported one case of anterior uveitis following the fourth injection of IVB that resolved with corticosteroids and cycloplegia [7].”
BackgroundSterile Endophthalmitis after Intravitreal Triamcinolone: A Possible Association with Uveitis
Taban, M., Singh, R. P., Chung, J. Y., Lowder, C. Y., Perez, V. L., & Kaiser, P. K. (2007) · American Journal of Ophthalmology · doi:10.1016/j.ajo.2007.03.051 · Cited by 39 · cited 3×
“Other factors that may be associated with a noninfectious inflammatory reaction with intravitreal injections include a prior history of uveitis, pseudophakia, and past history of vitrectomy [ 6 , 9]. Taban et al. reported that four of six cases of sterile endophthalmitis occurring after IVTA were in patients with a pr…”
BackgroundInfluential
Cited by
Efficacy of Intravitreal Bevacizumab for Stage 3+ Retinopathy of Prematurity
Mintz-Hittner, H. A., Kennedy, K. A., & Chuang, A. Z. (2011) · New England Journal of Medicine · doi:10.1056/nejmoa1007374 · Cited by 1,455
Shah, C. P., Garg, S. J., Vander, J. F., Brown, G. C., Kaiser, R. S., & Haller, J. A. (2011) · Ophthalmology · doi:10.1016/j.ophtha.2011.02.034 · Cited by 231
Liu, L., Ammar, D. A., Ross, L. A., Mandava, N., Kahook, M. Y., & Carpenter, J. F. (2011) · Investigative Opthalmology & Visual Science · doi:10.1167/iovs.10-6431 · Cited by 199
Anderson, W. J., da Cruz, N. F. S., Lima, L. H., Emerson, G. G., Rodrigues, E. B., & Melo, G. B. (2021) · International Journal of Retina and Vitreous · doi:10.1186/s40942-021-00307-7 · Cited by 155
van der Reis, M. I., Heij, E. C. L., de Jong‐Hesse, Y., Ringens, P. J., Hendrikse, F., & Schouten, J. (2011) · Retina · doi:10.1097/iae.0b013e3182278ab4 · Cited by 168
Metadata
- Authors
- Bakri, S. J., Larson, T. A., & Edwards, A. O.
- Affiliations
- Mayo Clinic (US)
- Corresponding author
- Bakri, Sophie J.
- ORCID
- Bakri, Sophie J.
- Venue
- Graefe's Archive for Clinical and Experimental Ophthalmology
- Published
- 2008-01-17
- Volume
- 246
- Issue
- 5
- Pages
- 779-781
- ISSN
- 0721-832X (ISSN-L)
- 1435-702X
- OpenAlex
- W2089838877
- Cited by
- 102
- References
- 11
- Citations by year
- 2026: 3 · 2025: 2 · 2024: 1 · 2023: 2 · 2022: 5 · 2021: 6 · 2020: 5 · 2019: 3 · 2018: 2 · 2017: 1 · 2016: 8 · 2015: 4 · 2014: 9 · 2013: 10 · 2012: 6
- FWCI
- 11.47
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Graefe s Archive for Clinical and Experimental Ophthalmology (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Ophthalmology › Ocular Diseases and Behçet’s Syndrome
- Health Sciences › Medicine › Ophthalmology › Ocular Infections and Treatments
- Health Sciences › Medicine › Ophthalmology › Retinal Diseases and Treatments
- Keywords
- bevacizumab, intravitreal injection, uveitis, intraocular inflammation, sterile inflammation, neovascular age-related macular degeneration, iritis, vitritis, corticosteroid therapy, adverse drug reactions
- MeSH terms
- Bevacizumab, Aged, Aged, 80 and over, Antibodies, Monoclonal, Female, Glucocorticoids, Humans, Injections, Macular Degeneration, Male, Uveitis, Anterior, Vitreous Body, Angiogenesis Inhibitors, Vascular Endothelial Growth Factor A, Antibodies, Monoclonal, Humanized
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Intraocular inflammation following intravitreal injection of bevacizumab. https://app.cochat.ai/papers/10.1007/s00417-007-0754-7
- The paper
- Bakri, S. J., Larson, T. A., & Edwards, A. O. (2008). Intraocular inflammation following intravitreal injection of bevacizumab. Graefe's Archive for Clinical and Experimental Ophthalmology. https://doi.org/10.1007/s00417-007-0754-7
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.